Intranasal Delivery of Engineered Neural Stem Cell-Derived Extracellular Vesicles Enables Targeted Delivery of Liraglutide to the Brain
Liraglutide (LG), a glucagon-like peptide-1 (GLP-1) receptor agonist, is approved for treating type 2 diabetes mellitus and as a weight loss drug in obesity. Recently, LG has emerged as a promising neuroprotective agent in suppressing neuroinflammation by modulating disease-associated inflammatory pathways in various...